The Centers for Disease Control and Prevention (CDC) on Wednesday, June 23, acknowledged that there is an association with heart inflammation, primarily in young people, after receiving Chinese Communist Party (CCP) Virus (COVID-19) mRNA vaccines, and that the vaccines should carry a warning statement, Children’s Health Defence reported.
Through a slide presentation, the CDC’s Advisory Committee on Immunisation Practices (ACIP) reported more than 1,200 cases of a rare heart inflammation disease in 16–to 24-year-olds who received the Pfizer or Moderna vaccine with the questionable mRNA technology.
As of June 11, the agency added that 267 cases of myocarditis or pericarditis were reported in people who had one shot of the mRNA vaccine and 827 cases after the second shot. There are 132 additional cases where the number of doses received is unknown.
Myocarditis is an inflammation of the heart muscle that can lead to cardiac arrhythmias and death. Pericarditis, meanwhile, refers to inflammation of the pericardium, which is the thin membrane surrounding the heart.
According to the National Organisation for Rare Disorders, myocarditis can result from infections but is most commonly “the result of the body’s immune reaction to the initial damage to the heart.”
The COVID-19 Vaccine Safety Technical Working Group (VaST) report says that the risk of myocarditis or pericarditis in young people is markedly higher in males and after the second dose.
In that regard, VaST co-chair Dr. Grace Lee said, “Clinical presentation of myocarditis cases following vaccination has been distinct, occurring most often within one week after dose two, with chest pain as the most common presentation.”
Meanwhile, Dr. Tom Shimabukuro, deputy director of the CDC’s Office of Immunisation Safety, told the presentation that data from one of the agency’s safety monitoring systems, Vaccine Safety Datalink (VSD), suggest a rate of 12.6 cases per million in the three weeks following the second dose in 12–39-year-olds.
Regarding these reports, Dr. Meryl Nass, an internal medicine physician, pointed out several flaws in the data used during the ACIP presentation. She said the presentation downplayed the rate of myocarditis in two ways, “The first was by grouping people aged 39 and older, even though the highest rates [of myocarditis] are in younger children, which lowers the rate.
“The second was to include only a very narrow period of time after the start of vaccination in the 12–15 year age group, thus omitting the vast majority of second doses, which is when about 75% or more of myocarditis cases occur.”
Dr. Nass also noted that the two genders were sometimes mixed, and “the rates in girls are much lower than in boys.”
In her presentation, Dr. Megan Wallance stated that the efficacy of Pfizer’s vaccine in the 12–15 age group is 100% and that Moderna’s was similar.
She compared myocarditis cases versus hospitalization rates for COVID-19 (CCP Virus) in 12–29-year-olds. She performed a risk/benefit analysis, which Dr. Nass said was inconsistent because “the myocarditis rate used is too low. But the risk from COVID is magnified.”
Dr. Nass further questioned that none of the nearly 6,000 deaths reported to VAERS (Vaccine Adverse Event Reporting System) were included in the ACIP presentations when determining risks and benefits.
According to Breitbart, more than 78 million people in the United States who consider themselves “fully vaccinated” opted for the two-dose Pfizer vaccine. More than 59 million received the two-dose Moderna vaccine. Meanwhile just under 12 million have received J&J’s single-dose vaccine.
That is, the vast majority of vaccinated Americans used the mRNA vaccine, which the CDC says “teaches our cells how to make a protein, or even just a part of a protein, that triggers an immune response inside our bodies.”
According to the CDC, hospitalization rates for adolescent COVID in the 12–17 age group were 2.1 per 100,000 in early January 2021 and 1.3 per 100,000 in April.
Of 204 hospitalizations assessed by the CDC from March 1, 2020, to April 24, 2021, there were no deaths. They even indicate that the COVID death rate in all adolescent age categories is less than 0.1%.
The agency continues to consider the statistics of vaccine-caused adverse events to be non-alarming, calling the heart conditions they cause rare and insignificant compared to the total number of Americans vaccinated.
Given that adolescents have a relatively zero risk of dying from the CCP Virus and have a very low level of experiencing serious events, it is alarming that more and more cases are coming to light, especially when the vaccination of children as young as six months of age is being considered.